Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -948.00 |
| Sep 30, 2021 | 4,801.00 |
| Jun 30, 2021 | 2,687.00 |
| Mar 31, 2021 | 11,023.00 |
| Dec 31, 2020 | -5,356.00 |
| Sep 30, 2020 | 46,397.00 |
| Jun 30, 2020 | 27,730.00 |
| Mar 31, 2020 | 468,826.00 |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 850,888.00 |
| Jun 30, 2019 | 3.99 Mn |
| Mar 31, 2019 | 1.65 Mn |
| Dec 31, 2018 | 98,483.00 |
| Sep 30, 2018 | 621,993.00 |
| Jun 30, 2018 | 767,256.00 |
| Mar 31, 2018 | -93,467.00 |
| Dec 31, 2017 | 36,828.00 |
| Sep 30, 2017 | 90,236.00 |
| Jun 30, 2017 | 47,585.00 |
| Mar 31, 2017 | 47,148.00 |
| Dec 31, 2016 | 74,035.00 |
| Sep 30, 2016 | 53,610.00 |
| Jun 30, 2016 | 33,203.00 |
| Mar 31, 2016 | 25,116.00 |
| Dec 31, 2015 | 57,972.00 |
| Sep 30, 2015 | 233,756.00 |
| Jun 30, 2015 | 101,264.00 |